TAS-103
| CAS No. | 174634-08-3 | Cat. No. | BCP20029 |
| Name | TAS-103 | ||
| Synonyms | TAS 103;TAS103; BMS247615; BMS 247615; BMS-247615; | ||
| Formula | C20H19N3O2 | M. Wt | 333.38 |
| Description | TAS-103, also known as BMS-247615, is a quinoline derivative that displays antitumor activity in murine and human tumor models. TAS-103 has been reported to be a potent topoisomerase II poison. TAS-103 showed the strongest antitumor activity among the conventional anticancer agents for colorectal cancer (p<0.05). The combination with CDDP augmented the antitumor activity of TAS-103 (p<0.05), indicating that CDDP is one of the most potent candidates to be used in combination with TAS-103 . TAS-103 may be useful in the chemotherapy of colorectal cancer. | ||
| Related Products | 174634-09-4（TAS-103 dihydrochloride） | ||
| Pathways | Cell Cycle/DNA Damage | ||
| Targets | Topoisomerase | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.